Dorman Products (DORM) Tops Q4 EPS by 16c, provdides guidance

Dorman Products (NASDAQ: DORM) reported Q4 EPS of $1.57, $0.16 better than the analyst estimate of $1.41. Revenue for the quarter came in at $494.3 million versus the consensus estimate of $494.86 million.

GUIDANCE:

Dorman Products sees FY2024 EPS of $5.40-$5.70, versus the consensus of $5.18.
The Company expects 2024 full year net sales growth in the range of 3% to 5% over 2023, diluted EPS in the range of $4.71 to $5.01.
This guidance assumes a tax rate of 24%, includes the impact of recent cost reduction actions and excludes any potential impacts from future acquisitions and divestitures, supply chain disruptions, significant inflation and interest rate changes, and share repurchases.

For earnings history and earnings-related data on Dorman Products (DORM) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Ledyard Financial Group adds two directors, three retire
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk